HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Shrikhande Selected Research

nicotinic receptor alpha4beta2

5/2010Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Shrikhande Research Topics

Disease

3Arthritis (Polyarthritis)
01/2001 - 09/2000
3Osteoporosis
01/2001 - 09/2000
1Tobacco Use Disorder (Nicotine Dependence)
05/2010

Drug/Important Bio-Agent (IBA)

3p38 Mitogen-Activated Protein KinasesIBA
01/2001 - 09/2000
1nicotinic receptor alpha4beta2IBA
05/2010
1dianiclineIBA
05/2010
1cytisineIBA
05/2010
1Varenicline (Chantix)FDA Link
05/2010
1Phosphotransferases (Kinase)IBA
01/2001
1CytokinesIBA
09/2000